Bone-Active Drugs in Pre-Menopausal Women with Breast Cancer Under Hormone Deprivation Therapies.
M F BirtoloR PedersiniAndrea PalermoW VenaE MorenghiG CristofoliniB PresciuttiniGaia TabaccoA M NaciuS PigniM LaganàF MazzoleniD CosentiniA CiafardiniM PaganiD FarinaL BalzariniA ZambelliR TorrisiL CianferottiNicola NapoliA C BossiA G LaniaAlfredo BerrutiGiovanna MantovaniPublished in: European journal of endocrinology (2024)
Pre-menopausal women under HDTs are at high risk of VFs in relationship with high BMI, densitometric diagnosis of osteoporosis, pre-existing VFs and family history of osteoporotic fractures. VFs in this setting might be effectively prevented by bisphosphonates or denosumab.